| Literature DB >> 16280075 |
Gunnar Toft1, Anna Axmon, Aleksander Giwercman, Ane Marie Thulstrup, Anna Rignell-Hydbom, Henning Sloth Pedersen, Jan K Ludwicki, Valentina Zvyezday, Andery Zinchuk, Marcello Spano, Gian Carlo Manicardi, Eva C Bonefeld-Jørgensen, Lars Hagmar, Jens Peter Bonde.
Abstract
BACKGROUND: Persistent organochlorine pollutants (POPs) may interfere with reproductive function but direct evidence in humans is very limited.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16280075 PMCID: PMC1308837 DOI: 10.1186/1476-069X-4-26
Source DB: PubMed Journal: Environ Health ISSN: 1476-069X Impact factor: 5.984
Target populations and data collection in an international study of fertility.
| Interviewed, n | 472 | 640 | 598 | 559 | 2269 |
| Participation rate, % | 68 | 26 | 90 | 39 | 43 |
| Contraceptive failures, % | 19 | 48 | 6 | 21 | 26 |
| Provided valid TTPc, n | 376 | 307 | 520 | 519 | 1722 |
| | |||||
| | |||||
| | |||||
| Questionnaire, mene, n | 472 | 576 | 637 | 195 | 1880 |
| Collected semen samplesf | 198 | 208 | 201 | 191 | 798 |
| Participation rate, % | 29 | 33 | 79 | 7 | 18 |
| | |||||
| | |||||
| |
a) Consecutive pregnant woman and their spouses.
b) Retrospective studies of past pregnancies.
c) TTP were considered not valid if the woman was using birth control when becoming pregnant (47 Inuits, 47 Warsaw women, and 297 Kharkiv women), did not provide information on whether she was using birth control (n = 26), was multipara and had not menstruated since her previous pregnancy (n = 16), or had not provided information on whether she had menstruated since her previous pregnancy (n = 5).
d) Possibly censored measure.
e) The total number of individuals with questionnaire information on males. Data were obtained by interviewing the spouse if no male interview was performed.
f) All collected semen samples were analysed for sperm concentration and volume.
Characteristics of women providing time to pregnancy interviews (n = 2269) and men providing semen samples (n = 798).
| Women | Men | Women | Men | Women | Men | Women | Men | |
| Age, mean (SD) | 29 (4) | 30 (4) | 25 (5) | 26 (5) | 27 (6) | 31 (7) | 29 (5) | 47 (10) |
| Employed, % | 89 | 97 | 61 | 75 | 51 | 83 | 70 | 95 |
| Body mass index, kg/m2, mean (SD) | 21 (3) | 26 (3) | 22 (3) | 24 (3) | 25 (4) | 26 (5) | 25 (4) | 27 (3) |
| Current smoking, % | 19 | 27 | 22 | 66 | 73 | 72 | 31 | 23 |
| Alcoholic beverage consumption, drinks/ week, mean (SD) | 2 (3) | 6 (6) | 1 (8) | 3 (2) | 2 (6) | 9 (14) | 1 (3) | n.a |
| Coffee, cups/week, mean (SD) | 1 (1) | 2 (2) | 2 (1) | 2 (2) | 2 (3) | 5 (5) | 3 (3) | n.a |
| Urogenital infectionsa, % | 14 | 5 | 13 | 5 | 85 | 83 | 27 | 21 |
| Urogenital disordersb, % | 21 | 3 | 12 | 3 | 7 | 1 | 44 | 2 |
| Primi parity, % | 91 | - | 79 | - | 31 | - | 4 | - |
| Intercourse daily, % | 18 | - | 19 | - | 42 | - | 4 | - |
a) Chlamydia infection, gonorrhoea, other sexually transmitted diseases or for women: Pelvic infections after delivery; for men: epididymitis or mumps in adulthood.
b) For women: Ovarian cysts, fibroids, myomas, endometriosis, cancer therapy and surgery on uterus, salpinges or ovaries. For men: Treatment for retracted testis, varicocele, testicular torsion, and testicular cancer.
Type of contraception by categories of time to pregnancy (TTP). Row percentages.
| Warsaw n = 376 | 25 | 1 | 31 | 28 | 7 | 8 |
| Kharkiv n = 307 | 3 | 1 | 16 | 40 | 16 | 24 |
| Greenland n = 520 | 39 | 16 | 5 | 4 | 27 | 9 |
| Sweden n = 519 | 25 | 29 | 25 | 9 | 0 | 10 |
| Warsaw n = 89 | 6 | 2 | 41 | 52 | 0 | 0 |
| Kharkiv n = 310 | 5 | 3 | 35 | 56 | 0 | 1 |
| Greenland n = 38 | 40 | 8 | 29 | 24 | 0 | 0 |
| Swedenc n = 150d | 29 | 10 | 15 | 3 | 0 | 42 |
| Warsaw n = 7 | 0 | 0 | 43 | 14 | 29 | 14 |
| Kharkiv n = 23 | 8 | 4 | 4 | 39 | 4 | 1 |
| Greenland n = 40 | 25 | 5 | 5 | 5 | 18 | 43 |
| Sweden n = 40 | 13 | 3 | 13 | 3 | 0 | 70 |
a) Time from a well defined start of unprotected sexual intercourse until last menstrual period
b) Became pregnant in spite of use of contraception
c) Frequencies based upon first unplanned pregnancies
d) The number of unplanned latest pregnancies
e) Including women that became pregnant following delivery without recurrence of menstrual bleeding (n = 16)
Fecundability ratiosa (FR) for couples in Kharkiv, Greenland and Sweden in comparison with couples in Warsaw.
| 208 (55) | 38 (10) | 60 (16) | 70 (19) | 1.00 | 1.00 | - | |
| 147 (48) | 37 (12) | 39 (13) | 84 (27) | 0.80 | 0.64 | 0.53 – 0.79 | |
| 295 (57) | 61 (12) | 85 (46) | 80 (15) | 1.07 | 1.00 | 0.80 – 1.27 | |
| 355 (68) | 75 (15) | 36 (7) | 53 (10) | 1.35 | 1.26 | 1.01 – 1.57 | |
a) Adjustment for female age (continuous), female current smoking (yes/no), primiparity (yes/no), daily sexual intercourse (yes/no) and current employment (yes/no). All covariates except current employment contributed significantly to the model. Female urogenital disease or infection, low and high body mass index and use of oral contraceptives did not change at least one of the risk estimates with at least 10%.
b) The corresponding age and smoking adjusted FR among nulliparous women were (i) Kharkiv: 0.59 (95% CI, N = 503) (ii) Greenland: 0.90 (95% CI 0.68–1.19, N = 187) and Sweden FR 0.90, (95% CI 0.73 – 1.11), N = 429]. The Swedish risk estimate based upon the first planned pregnancy.
Fecundability ratiosa (FR) for couples providing semen samples in comparison with couples not providing semenb.
| Warsaw | |||||||
| - sample | 123 (56) | 23 (10) | 37 (17) | 38 (17) | 1.00 | 1.00 | - |
| +sample | 85 (55) | 15 (10) | 23 (15) | 32 (20) | 0.91 | 0.90 | 0.7 – 1.1 |
| Kharkiv | |||||||
| - sample | 103 (49) | 27 (13) | 27 (13) | 53 (25) | 1.00 | 1.00 | - |
| +sample | 44 (46) | 10 (10) | 12 (12) | 31 (32) | 0.87 | 1.02 | 0.8 – 1.4 |
| Greenland | |||||||
| - sample | 205 (60) | 33 (10) | 50 (15) | 53 (16) | 1.00 | 1.00 | - |
| +sample | 89 (50) | 28 (15) | 35 (20) | 27 (15) | 0.89 | 0.88 | 0.7 – 1.1 |
| All | |||||||
| - sample | 431 (56) | 83 (11) | 114 (15) | 144 (19) | 1.00 | 1.00 | - |
| +sample | 218 (51) | 53 (12) | 70 (16) | 90 (21) | 0.89 | 0.91 | 0.80 – 1.04 |
a) Adjustment for region (only the overall estimate), female age (continuous) and current female smoking (yes/no).
b) Sweden not included (TTP and semen studies with marginal overlap).
Unadjusted semen characteristics by region.
| Sperm concentration × 106/ml | ||||
| mean (SD) | 88 (80) | 75 (61) | 72 (61) | 57 (44) |
| median (p5 – p95) | 64 (7–258) | 59 (10–193) | 53 (11–178) | 49 (9–166) |
| Total sperm count × 106 | ||||
| mean (SD) | 343 (374) | 255 (238) | 245 (241) | 182 (159) |
| median (p5 – p95) | 197 (19–1071) | 181 (24–746) | 186 (32–667) | 133 (15–500) |
| Volume ml, mean (SD) | 3.8 (1.8) | 3.5 (1.9) | 3.5 (1.7) | 3.3 (1.7) |
| A+B motile, % (SD) | 60 (20) | 54 (22) | 55 (19) | 57 (21) |
| CASA, motile, % (SD) | 42 (22) | not performed | 50 (21) | 32 (21) |
| Normal morphology, % (SD) | 6.7 (3.8) | 7.3 (4.2) | 6.9 (3.7) | 8.2 (4.5) |
| Abstinence period a, days, | ||||
| mean (SD) | 7.7 (9.5) | 3.9 (2.0) | 3.5 (3.1) | 3.7 (2.6) |
| median (p5 – p95) | 4.0 (1.0–30.0) | 3.0 (1.5–7.0) | 3.0 (0.5–7.0) | 3.0 (1.0–8.0) |
| Time to analysis, minutes, mean (SD) | 52 (8) | 37 (12) | 35 (18) | 44 (12) |
| Season for sperm collection, % | ||||
| Spring | 19 | 26 | 32 | 34 |
| Summer | 10 | 22 | 54 | 35 |
| Fall | 21 | 24 | 14 | 31 |
| Winter | 50 | 28 | 0 | 0 |
| Fever last three months, % | 9 | 10 | 13 | 3 |
| Pain at urination last three months, % | 2 | 19 | 3 | 0 |
| Infections, vaccines or surgery last six months, % | 26 | 72 | 12 | 8 |
| Medicine or natural medicine use last six months, % | 33 | 68 | 32 | 33 |
| Spillage of semen, % | 6 | 17 | 11 | 16 |
a) Abstinence time only included from subjects reporting abstinence time <60 days.
Geometric mean values and the 95% confidence interval for semen characteristics by region.
| Sperm concentration, mill/ml | 51 (44;58) | 55 (49;61) | 57 (50;64) | 45 (39;52) | 0.04/0.08 |
| Urogenital infections | 23 (14; 40) | 50 (30;82) | 44 (33;58) | 0.22/0.02 | |
| No urogenital infection | 54 (47;62) | 56 (50;64) | 62 (46; 83) | 47 (40;54) | 0.07/0.19 |
| Sperm countc, millions | 164 (142;188) | 179 (155;206) | 180 (156;207) | 146 (123;173) | 0.08/0.22 |
| Motile spermatozoad, % | 60 (57; 63) | 56 (53; 60) | 0.02/0.02 | ||
| Normal morphology, % | 6.7 (6.2;7.3) | 7.1 (6.5;7.6) | 7.1 (6.5;7.6) | 7.9 (7.2;8.7) | 0.07/0.07 |
Figures in bold indicate p < 0.05 in pair-wise comparisons with the Warsaw sample as reference (Dunnett method).
a) Men that have ever fathered a child.
b) Period of abstinence, count values only.|
c) Restricted to men reporting no spillage.
d) Arithmetical mean values.